| Cephalon says drug fails anxiety disorder trial |
|
| Written by Administrator | |
|
Cephalon Inc. said on Monday a pivotal-stage trial failed to show its epilepsy drug, Gabitril, is effective for treating generalized anxiety disorder. (full story) |
| < Prev |
|---|
| Related Resources |
|---|